Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph III Randomized Mk-3475In Muscle Invasive And Locally Advanced Urothelial Carcinoma Versus Observa

Protocol: ALLIANCE-A031501

Full Title

Phase III Randomized Adjuvant Study Of Mk-3475 (Pembrolizumab) In Muscle Invasive And Locally Advanced Urothelial Carcinoma (Ambassador) Versus Observation

Genitourinary Cancers Bladder Cancer